- Varian Medical Systems (NYSE:VAR) Fiscal Q1 Results ($M): Total Revenues: 737.9 (+3.7%); Total Gross Orders: 725.8 (+10.7%), Oncology Systems: 561.7 (+5.3%), Imaging Systems: 162.7 (+50.4%); Order Backlog: 3,124.3 (+12.9%).
- COGS: 410.9 (+2.2%); R&D Expense: 57.1 (-1.6%); SG&A Expense: 140.4 (+28.1%); Net Income: 93.3 (-4.8%); EPS: 0.92 (+1.1%); Quick Assets: 972.9 (-6.9%).
- Gross Profit: 327.0 (+5.6%); COGS: 55.7% (-1.4%); Gross Margin: 44.3% (+1.8%); Operating Earnings: 129.5 (-8.8%); Operating Earnings Yield: 17.5% (-12.1%); Net Earnings Yield: 12.6% (-8.2%).
- 2015 Guidance: EPS: $4.16 - 4.26 (unch); Total Revenue Growth: ~5%; Oncology/Imaging Sales Growth: 5 - 6%.
- Fiscal Q2 Guidance: Oncology/Imaging Sales Growth: 0 - 2%; EPS: $0.98 - 1.02 from $0.76 - 0.80.